STOCK TITAN

Allient (ALNT) 10-Q Filings

ALNT NASDAQ

Here are the 10-Q quarterly reports from Allient Inc. (ALNT) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A 10-Q covers the quarterly report filed between annual reports, so if you follow ALNT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full ALNT filings page.

Rhea-AI Summary

Allient Inc. (ALNT) reported third-quarter 2026 revenue of $164.4 million, compared with $138.7 million a year earlier. Net income was $15.3 million, versus $6.5 million, and diluted earnings per share were $0.91, versus $0.39. Gross margin was 36.6%, compared with 33.3%.

For the first nine months of 2026, revenue was $457.1 million versus $411.1 million, and net income was $31.1 million versus $15.7 million. Third-quarter bookings were $218.1 million, versus $133.1 million, and backlog was $351.5 million versus $231.0 million. Net cash provided by operating activities was $22.1 million, compared with $43.1 million.

Allient declared a quarterly dividend of $0.04 per share in the second and third quarters of 2026, after $0.03 per share in the first quarter. It expects a 21% to 23% income tax rate for full-year 2026. Approximately $2 million in restructuring costs are anticipated for 2026, primarily employee severance and personnel-related expenses, and are expected to be substantively paid by year-end.

Rhea-AI Summary

Allient Inc., a precision motion, controls and power solutions provider, delivered stronger results for the quarter ended June 30, 2026. Revenue rose to $153,770 (in thousands) from $139,578 (in thousands), driven mainly by Industrial and Aerospace & Defense markets and 9.3% organic growth. Gross margin improved to from 33.2%. Net income nearly doubled to $10,391 (in thousands), with diluted EPS of $0.61 versus $0.34. Adjusted net income reached $13,545 (in thousands) and adjusted EPS $0.80; EBITDA was $21,733 (in thousands) and adjusted EBITDA $23,715 (in thousands).

Demand indicators strengthened, with quarterly bookings of $201,302 (in thousands) and backlog of $298,031 (in thousands), up 49% and 26% year over year, respectively. Year-to-date operating cash flow was $20,127 (in thousands), below the prior year as working capital increased, while cash stood at $42,088 (in thousands) and long-term debt at $173,337 (in thousands) with $162,038 (in thousands) of revolver capacity available. The Simplify to Accelerate NOW restructuring, including consolidating assembly from Dothan into Tulsa and Reynosa, generated $1,503 (in thousands) of costs in the first half of 2026, with $2–$3 million expected for the year to support efficiency and margin. Allient is also pursuing refunds of certain 2025 tariffs following a 2026 Supreme Court ruling, though no refunds have been received.

Rhea-AI Summary

Allient Inc. reported stronger results for the three months ended March 31, 2026. Revenue rose to $138.9M from $132.8M, driven mainly by Industrial and Vehicle markets and modest foreign currency tailwinds, lifting gross margin to 32.7% from 32.2%.

Net income increased to $5.4M from $3.6M, with diluted EPS up to $0.32 from $0.21, helped by lower interest expense and operational gains from the Simplify to Accelerate NOW program. Non‑GAAP adjusted net income was $8.4M, or $0.50 per diluted share, and Adjusted EBITDA was $17.3M.

Bookings reached $158.1M and backlog was $251.0M, both above the prior year. Allient ended the quarter with cash of $41.2M, long‑term debt of $177.3M, and $158.0M of unused capacity under its revolving credit facility, while remaining in compliance with leverage and interest coverage covenants.

Rhea-AI Summary

Allient Inc. (ALNT) reported stronger Q3 results. Revenue rose to $138,743 (from $125,213 a year ago) and gross profit increased to $46,181. Operating income nearly doubled to $12,180, and net income improved to $6,477, translating to diluted EPS of $0.39 (from $0.13). Growth was broad-based across target markets, led by Industrial at $71,023, with Medical at $21,656 and Aerospace & Defense at $18,755.

Balance sheet and cash flow strengthened. Cash stood at $39,476, and long‑term debt decreased to $190,259. Year‑to‑date operating cash flow was $43,116, supporting capital spending of $5,090 and dividends of $0.03 per quarter. Stockholders’ equity increased to $294,172. The company maintained ample liquidity with an unused Revolving Facility of $145,037 as of September 30, 2025. Allient continued realignment under its “Simplify to Accelerate NOW” strategy, incurring $3,457 in restructuring costs year‑to‑date, with total costs expected to be approximately $4 to $5 million by year‑end. Shares outstanding were 16,943,497 as of November 5, 2025.

Form 10-Q